Pharmaceutical Packaging Market by Type, Delivery Mode, Level of Packaging, Material, End User

Description

List of Tables

[183 Pages Report] The Pharmaceutical Packaging Market size was estimated at USD 156.87 billion in 2023 and expected to reach USD 173.13 billion in 2024, at a CAGR 10.06% to reach USD 307.05 billion by 2030.

Pharmaceutical packaging refers to the processes and materials used to encase and protect pharmaceutical products. It includes a range of container types like bottles, vials, blisters, tubes, syringes, ampoules, closures, labels, and secondary packaging materials. The packaging is designed to provide barrier protection, convenience in handling, and convey essential information about the medications. Pharmaceutical packaging has a critical role in ensuring the safety, quality, and efficacy of drugs. It serves numerous applications, including providing barrier protection against environmental factors and child resistance and accommodating the demands of specific modes of drug delivery. The primary end-users of pharmaceutical packaging are pharmaceutical manufacturers, healthcare providers, and patients. Growth in the pharmaceutical packaging market is influenced by several factors, such as growing smart packaging for patient engagement and identification, rising demand for primary pharmaceutical packaging, and increasing demand for biologics packaging. Moreover, stricter regulations for packaging in terms of child resistance and tamper-evidence boost innovation and compliance-related investments. However, the expansion of pharmaceutical packaging is hindered by the price volatility of pharmaceutical packaging raw materials, adherence to the global and local regulatory landscape, and meeting sustainability goals while maintaining the integrity of the packaging. On the other hand, the latest opportunities within the pharmaceutical packaging market include the evolution of nanotechnology due to innovative and new-generation packaging solutions, the emergence of eco-friendly and sustainable packaging solutions, and the customization of packaging for personalized treatment protocols.

KEY MARKET STATISTICS
Base Year [2023]	USD 156.87 billion
Estimated Year [2024]	USD 173.13 billion
Forecast Year [2030]	USD 307.05 billion
CAGR (%)	10.06%

Type: Increasing preference for blister packs for pharmaceutical packaging due to resistance against humidity and contaminants

Ampoules are small sealed glass or plastic vessels that are used to contain and protect a sample of a pharmaceutical from air, contamination, or tampering. They are typically used to store pharmaceuticals in liquid form and are ideal for single-use applications, maintaining sterility. Blister packs are pre-formed plastic packaging solutions that accommodate tablets or capsules, providing a barrier against external factors such as humidity and contaminants. They are extensively used due to their convenience for dose administration and adherence, with child-resistant designs being particularly preferred for safety purposes. Caps and closures are critical components of pharmaceutical packaging, providing the integrity and safety of the product. They range from simple screw caps to complex child-resistant and tamper-evident designs. Cartridges serve a purpose in the administration of drugs, especially for conditions like diabetes, where self-injection is common. They offer an alternative to vials for multi-dose applications and are preferred when using pen injectors. Labels and accessories are indispensable for pharmaceutical packaging, serving as branding and informational mediums and as anti-counterfeiting tools. Smart labels with RFID technology for tracking and temperature-sensitive labels for cold chain management are gaining traction. Plastic bottles are a common packaging choice for a wide range of pharmaceutical products, from liquid syrups to tablets. Demand for these is high due to their lightweight nature and durability. Importantly, manufacturers are now concentrating on producing recyclable plastic bottles to reduce environmental impact. Pouches, often used for powdered or granulated pharmaceutical products, offer lightweight and flexible packaging solutions. They are especially preferred for products that require protection from moisture and light. Pre-filled inhalers provide users with ready-to-administer doses of medication for conditions such as asthma and chronic obstructive pulmonary disease. Pre-filled syringes have become popular due to their ease of use, reduced risk of dosing errors, and efficient delivery of various injectables. Vials are small bottles typically used for holding liquid medications. They are essential for multi-dose applications and are prized for their compatibility with multiple drug types. Each pharmaceutical packaging type caters to different needs within the market. Ampoules and vials favor parenteral applications with an emphasis on sterility. Pre-filled options, such as syringes and inhalers, prioritize convenience and dose accuracy. Bottles and pouches are geared towards the over-the-counter market, where ease of transport and storage are key. Blister packs and cartridges are increasingly preferred for their patient adherence and ease of use features. Caps, closures, labels, and accessories play supporting roles across the board, focusing on securing the product and providing vital information. The recent trend across all categories is the shift towards sustainable materials and environmentally-friendly manufacturing processes.

End User: Rising demand in pharmaceutical manufacturing for maintaining product integrity and extending shelf life

Contract packaging, or pharma co-packing, involves outsourcing pharmaceutical packaging to a third-party service provider. Clients prefer this segment when they require scalability, speed to market, and cost-efficiency without investing in in-house packaging facilities. Cost savings, expertise, state-of-the-art technology, and regulatory compliance are the primary driving factors for contract packaging. Institutional pharmacy refers to pharmacies within institutions like hospitals, clinics, and nursing homes. These entities require efficient packaging that maintains medication integrity and promotes adherence in high-turnover patient care settings. Emphasis is on patient-specific, unit-dose packaging, which enhances safety, reduces waste, and complies with stringent regulations. The Pharmaceutical manufacturing segment encompasses companies involved in the production of drugs and medications. These manufacturers prioritize packaging that protects product integrity, extends shelf life, and complies with regulations across various markets. This focuses on customization, barrier properties, and compliance with international standards such as FDA and EMA guidelines. Retail pharmacy is the most direct interface between medications and consumers, with packaging that safeguards the medication, influences consumer behaviors, and presents brand identity. Consumer convenience, child-resistant features, informational labeling, and branding are the core preferences for retail pharmacies.

Regional Insights

The United States stands as a prominent country for pharmaceutical packaging, driven by advanced healthcare infrastructure, stringent regulatory frameworks, and a high demand for drug delivery solutions. Regarding investments and initiatives, the US market is witnessing substantial growth in the biologics sector, necessitating sophisticated packaging solutions for sensitive products. Companies in the region continuously file patents for groundbreaking packaging designs and materials. In South America, rising healthcare expenditures and increasing access to healthcare services in countries such as Brazil and Argentina facilitate the growth of pharmaceutical packaging. The pharmaceutical packaging market in EU countries is highly regulated, focusing on patient safety and anti-counterfeiting measures. Patient-centric designs and adherence-compliant packaging are primary consumer needs across this region. Customers tend to favor packaging that integrates security features and promotes sustainability. EU initiatives often involve developing eco-friendly packaging materials and recycling programs. In wealthier nations within the Middle East, there is an increasing demand for high-quality pharmaceutical packaging that aligns with international standards. Africa, being a resource-limited setting, tends to focus on affordable and functional packaging solutions. However, there is an emerging focus on improving quality and counteracting counterfeit medications. The pharmaceutical packaging market in the APAC region is currently the fastest-growing globally due to rapidly developing healthcare sectors, increased healthcare spending, and a growing elderly population, especially in countries such as China, Japan, and Australia. The Chinese government's policies promoting innovation in pharmaceuticals have increased customer expectations for advanced packaging. Japan's pharmaceutical packaging market is developed, emphasizing precision, quality, and product integrity. The aging population leads to a consumer need for easy-to-use and senior-friendly packaging. India's pharmaceutical packaging market is characterized by cost-effectiveness due to the country's role as a significant exporter of generic drugs.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pharmaceutical Packaging Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmaceutical Packaging Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Packaging Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Amcor PLC, AptarGroup, Inc., Becton, Dickinson and Company, Berry Global, Inc., Catalent, Inc., CCL Industries Inc., Comar, LLC, Constantia Flexibles, Drug Plastics Group, EPL Limited, Gaplast GmbH, Gerresheimer AG, Klockner Pentaplast Group, Lonza Group AG, McKesson Corporation, Mondi PLC, Nipro Corporation, Nolato AB, Origin Pharma Packaging, Schott AG, Sealed Air Corporation, SGD S.A., URSATEC GmbH, Vetter Pharma-Fertigung GmbH & Co. KG, W. L. Gore & Associates Inc., West Pharmaceutical Services, Inc., and Westrock Company by Smurfit Kappa Group.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Packaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Ampoules
- Blister Packs
- Caps & Closures
- Cartridges
- Labels & Accessories
- Plastic Bottles
- Pouches
- Pre-Filled Inhalers
- Pre-Filled Syringes
- Vials

Delivery Mode
- Injectables
- IV Drugs
- Nasal
- Ocular
- Oral
- Pulmonary
- Topical
- Transdermal

Level of Packaging
- Primary
- Secondary
- Tertiary

Material
- Aluminum Foil
- Glass
- Paper
- Plastics & Polymers
  - Polyethylene (PE)
  - Polyethylene terephthalate (PET)
  - Polypropylene (PP)
  - Polystyrene (PS)
  - Polyvinyl Chloride (PVC)
End User
- Contract Packaging
- Institutional Pharmacy
- Pharmaceutical Manufacturing
- Retail Pharmacy

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Pharmaceutical Packaging Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmaceutical Packaging Market?

3. What are the technology trends and regulatory frameworks in the Pharmaceutical Packaging Market?

4. What is the market share of the leading vendors in the Pharmaceutical Packaging Market?

5. Which modes and strategic moves are suitable for entering the Pharmaceutical Packaging Market?

Product Code: MRR-434CCDA04670

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing Smart Packaging for Patient Engagement and Identification
  - 5.1.1.2. Growing Demand for Primary Pharmaceutical Packaging
  - 5.1.1.3. Increasing Demand for Biologics Packaging
- 5.1.2. Restraints
  - 5.1.2.1. Price Volatility of Pharmaceutical Packaging Raw Materials
- 5.1.3. Opportunities
  - 5.1.3.1. Evolution of Nanotechnology due to Innovative and New Generation Packaging Solutions
  - 5.1.3.2. Emergence of Sustainable and Eco-Friendly Packaging Solutions
- 5.1.4. Challenges
  - 5.1.4.1. Stringent Regulatory Compliance
5.2. Market Segmentation Analysis
- 5.2.1. Type: Increasing preference for blister packs for pharmaceutical packaging due to resistance against humidity and contaminants
- 5.2.2. End User: Rising demand in pharmaceutical manufacturing for maintaining product integrity and extending shelf life
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization

6. Pharmaceutical Packaging Market, by Type

6.1. Introduction
6.2. Ampoules
6.3. Blister Packs
6.4. Caps & Closures
6.5. Cartridges
6.6. Labels & Accessories
6.7. Plastic Bottles
6.8. Pouches
6.9. Pre-Filled Inhalers
6.10. Pre-Filled Syringes
6.11. Vials

7. Pharmaceutical Packaging Market, by Delivery Mode

7.1. Introduction
7.2. Injectables
7.3. IV Drugs
7.4. Nasal
7.5. Ocular
7.6. Oral
7.7. Pulmonary
7.8. Topical
7.9. Transdermal

8. Pharmaceutical Packaging Market, by Level of Packaging

8.1. Introduction
8.2. Primary
8.3. Secondary
8.4. Tertiary

9. Pharmaceutical Packaging Market, by Material

9.1. Introduction
9.2. Aluminum Foil
9.3. Glass
9.4. Paper
9.5. Plastics & Polymers

10. Pharmaceutical Packaging Market, by End User

10.1. Introduction
10.2. Contract Packaging
10.3. Institutional Pharmacy
10.4. Pharmaceutical Manufacturing
10.5. Retail Pharmacy

11. Americas Pharmaceutical Packaging Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Pharmaceutical Packaging Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Pharmaceutical Packaging Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
- 14.3.1. Bormioli Pharma, Loop Partner on Pharmaceutical Packaging
- 14.3.2. Stoelzle Pharma launches the PharmaCos packaging line
- 14.3.3. PLUSS launches two new temp-controlled pharma packaging solutions
- 14.3.4. Smurfit Kappa strikes deal to acquire WestRock

15. Competitive Portfolio

15.1. Key Company Profiles
15.2. Key Product Portfolio